Global Multiomics Industry Trends: Where the Market Is Headed by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Multiomics Market Size Likely To Evolve From 2025 Through 2034?

The multiomics market has observed rapid expansion in recent years. This market is projected to grow from $3.27 billion in 2024 to $3.85 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.7%. The historical progression can be ascribed to elements such as an uptick in biomedical research, augmented government and private financial backing, a rise in the incidence of chronic diseases, ongoing technological advancements, and the enhancement of computational tools and software designed for data analysis.

The multiomics market size is anticipated to experience substantial growth over the next few years. It is projected to expand to $7.11 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 16.6%. This expected growth during the forecast period can be attributed to progress in artificial intelligence and machine learning, the broadening of clinical applications, a flourishing biopharmaceutical industry, the introduction of integrated multiomics platforms, and its increasing application in agricultural and environmental research. Significant trends during this period include technological innovations, the release of new commercial multiomics platforms, the incorporation of spatially resolved multiomics analysis, its use in biopharmaceutical research and development, and its expansion into clinical diagnostics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

Which Drivers Are Impacting The Multiomics Market?

The anticipated expansion of the multiomics market is closely linked to the growing requirement for personalized medicine. Personalized medicine defines a medical strategy that customizes healthcare decisions and treatment plans for individual patients, considering their genetic, environmental, and lifestyle profiles. This tailored medical approach is becoming more prevalent due to technological advancements, a heightened demand for targeted therapies, and enhancements across global healthcare systems. Multiomics aids personalized medicine by offering a thorough understanding of an individual’s genetic, molecular, and metabolic profile, allowing healthcare professionals to adapt treatments according to the distinct characteristics of each patient. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA sanctioned 16 novel personalized therapies for patients with rare diseases in 2023, an increase from 6 in 2022. Consequently, the rising demand for personalized medicine is a primary force propelling the growth of the multiomics market.

What Are The Primary Types Of Segments Analyzed In The Multiomics Market?

The multiomicsmarket covered in this report is segmented –

1) By Type: Single-Cell Multiomics; Bulk Multiomics

2) By Platform: Genomics; Transcriptomics; Proteomics; Metabolomics; Integrated Omics Platforms

3) By Application: Diagnostics; Drug Discovery And Development; Personalized Medicine; AgriGenomics; Other Applications

4) By End User: Academics And Research Organization; Pharmaceutical And Biotechnology Companies; Clinical research Organization; Other End-Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics; Single-Cell Transcriptomics; Single-Cell Epigenomics; Single-Cell Proteomics; Single-Cell Metabolomics

2) By Bulk Multiomics: Genomics; Transcriptomics; Epigenomics; Proteomics; Metabolomics

What Are The Major Trends Driving The Growth Of The Multiomics Market?

Major companies in the multiomics market are developing advanced single-cell multiomics platforms, enabling scientists to perform large-scale studies without compromising sample integrity. These platforms merge various omics disciplines with artificial intelligence capabilities, allowing users to effortlessly analyze and interpret complex biological data through sophisticated algorithms and machine learning methods. For example, in February 2023, Becton, Dickinson, and Company, a US-based medical device company, introduced the BD Rhapsody HT Xpress, a high-throughput single-cell multiomics platform. This innovative system allows scientists to isolate, barcode, and analyze single cells with high sample throughput, accommodating up to eight times more cells than prior versions of BD single-cell analyzers. The BD Rhapsody HT Xpress System ensures no sample loss, providing the flexibility to analyze multiple samples and different cell sizes and types concurrently, such as stem cells or cancer cells, thereby enhancing researchers’ ability to gain deeper insights in less time.

Who Are The Prominent Global Companies Shaping The Multiomics Market?

Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Multiomics Market?

North America was the largest region in the multiomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Multiomics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15866&type=smp

Browse Through More Reports Similar to the Global Multiomics Market 2025, By The Business Research Company

Multidrug Resistant Bacteria Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/multidrug-resistant-bacteria-global-market-report

Multi Family Housing Green Buildings Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/multi-family-housing-green-buildings-global-market-report

Multimode Fiber Cable Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/multimode-fiber-cable-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795